Bio-Techne Corp (TECH) Social Stream



Bio-Techne Corp (TECH): $79.16

-1.69 (-2.09%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TECH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

BIO-TECHNE CORP (TECH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering TECH.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 9 $600 $400 $510.625 $80.85 531.57%
2021-12-01 9 $600 $400 $511.875 $80.85 533.12%
2022-02-01 9 $600 $400 $506.25 $80.85 526.16%
2022-03-01 6 $600 $540 $565 $80.85 598.82%
2022-04-25 7 $600 $370 $532.5 $80.85 558.63%
2022-05-05 7 $575 $370 $515.833 $80.85 538.01%
2022-06-06 7 $575 $370 $506.428 $80.85 526.38%
2022-08-04 6 $580 $370 $507.142 $80.85 527.26%
2022-08-05 6 $580 $370 $491.428 $80.85 507.83%
2022-09-22 6 $580 $360 $490 $80.85 506.06%
2022-10-19 6 $550 $360 $485.714 $80.85 500.76%
2022-11-01 6 $550 $360 $477.142 $80.85 490.16%
2022-11-02 6 $500 $360 $442.5 $80.85 447.31%
2022-12-05 6 $125 $90 $110.625 $80.85 36.83%
2022-12-07 7 $125 $89 $108.222 $80.85 33.86%
2022-12-12 8 $125 $89 $107.4 $80.85 32.84%
2023-01-06 9 $125 $89 $106.727 $80.85 32.01%
2023-01-24 9 $125 $89 $106.727 $80.85 32.01%

The Trend in the Analyst Price Target


Over the past 38 weeks, TECH's average price target has gone down $409.11.

TECH reports an average of 33.79% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-05 7 575 370 513.571 386.15 33%
2022-07-14 6 580 370 507.142 341.39 48.55%
2022-11-02 6 500 360 442.500 297.95 48.51%
2022-12-07 7 125 89 108.222 80.67 34.15%
2023-01-24 9 125 89 106.727 80.15 33.16%

TECH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.44 7 0 2 0 0 9

The Trend in the Broker Recommendations


TECH's average broker recommendation rating worsened by 0.44 over the prior 44 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, BIO-TECHNE CORP's average analyst price target is higher than 2323.04% of them.
  • BIO-TECHNE CORP's upside potential (average analyst target price relative to current price) is greater than 2305.11% of stocks in the large market cap category.
  • In terms of how BIO-TECHNE CORP fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 355.61% of that group.
  • BIO-TECHNE CORP's variance in analysts' estimates is lower than -456.47% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, RGEN, AMGN, and DNA are the three stocks most similar to BIO-TECHNE CORP regarding the price target and analyst recommendation information presented here.

What is the outlook for TECH? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8065 seconds.